Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 6 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact6 DOIs

DOIs for this ISSN

Showing the top 5 of 119 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Maternal Medication Use in Pregnancy: A Narrative Review on… (10.3390/pharma3040023)	ORCID	15.05	3
2	Depression Events Associated with Proton-Pump Inhibitors in… (10.3390/pharma2030023)	ORCID	11.93	2
3	Utilization of Real-World Data to Facilitate Clinical Trials… (10.3390/pharma3030017)	ORCID	11.93	2
4	Ocular Chloramphenicol Exposure in Early Childhood in Aotear… (10.3390/pharma3020014)	ORCID	7.53	1
5	Trend of Antihypertensive Medicine Use in the Baltic States… (10.3390/pharma1010001)		0.00	1
6	Multimedication Guidelines: Assessment of the Size of the Ta… (10.3390/pharma1010002)		0.00	8
7	Risk of Obstructive Sleep Apnea in Adults with Resistant Hyp… (10.3390/pharma1010003)		0.00	1
8	Welcome to Pharmacoepidemiology—An Open Access Journal (10.3390/pharma1010004)		0.00	0
9	Multimedication in Family Doctor Practices: The German Evide… (10.3390/pharma1010005)		0.00	2
10	The Complexity in the Diagnosis and Treatment of Symptoms in… (10.3390/pharma1020006)	ORCID	0.00	0
11	Non-Cardiac Depolarization-Blocking Drugs Are Associated wit… (10.3390/pharma1020007)		0.00	4
12	Medication Use among Immigrants from Syria Living in Western… (10.3390/pharma1020008)		0.00	3
13	Spironolactone Utilization among Patients with Reduced and P… (10.3390/pharma1030009)		0.00	3
14	Evaluation of the Effectiveness of Buprenorphine-Naloxone on… (10.3390/pharma1030010)		0.00	9
15	Identifying Surgical and Trauma Patients in New Zealand for… (10.3390/pharma2010001)		0.00	5
16	Birth Outcomes of Anticancer Drug Prescriptions during Pregn… (10.3390/pharma2010002)		0.00	1
17	Signal Detection Study Focusing on Differences in the Drug D… (10.3390/pharma2010003)		0.00	2
18	Clinical Indicators of Cardiovascular Risk in Adult Patients… (10.3390/pharma2010004)		0.00	0
19	Prescribing Patterns of Antibiotics According to the WHO AWa… (10.3390/pharma2010005)		0.00	45
20	Pregnancy- and Birth-Related Experiences among Postpartum Wo… (10.3390/pharma2010006)		0.00	1
21	Knowledge and Practices among Dental Practitioners Regarding… (10.3390/pharma2010007)		0.00	3
22	The Era of Rhythm Control: A Review of the Epidemiology and… (10.3390/pharma2010008)		0.00	2
23	Absolute Risk Reductions in COVID-19 Antiviral Medication Cl… (10.3390/pharma2010009)		0.00	3
24	Effects of Electronic Cigarette Use on Cardiovascular-Diseas… (10.3390/pharma2010010)		0.00	0
25	Do Propylene Glycol, Benzyl Alcohol, and Ethanol in Concomit… (10.3390/pharma2020011)		0.00	0
26	Cost Estimations of Managing Adverse Drug Reactions in Hospi… (10.3390/pharma2020012)		0.00	15
27	Feasibility of Using Oncology-Specific Electronic Health Rec… (10.3390/pharma2020013)		0.00	2
28	General Practitioner-Related Factors Associated with Antibio… (10.3390/pharma2020014)		0.00	2
29	Treatment-Related Late Adverse Events in Childhood Cancer Su… (10.3390/pharma2020015)		0.00	0
30	Patient Characteristics Associated with Repeat Antibiotic Pr… (10.3390/pharma2020016)		0.00	2
31	COVID-19 and the COVID-19 Vaccine in Japan—A Review from a G… (10.3390/pharma2030017)		0.00	7
32	Antidepressants and the Risk of Fall-Related Injury in Older… (10.3390/pharma2030018)		0.00	5
33	Phenotyping Diabetes Mellitus on Aggregated Electronic Healt… (10.3390/pharma2030019)		0.00	1
34	Suspected Suicide Attempt and Intentional Misuse Cases Aged… (10.3390/pharma2030020)		0.00	0
35	Drug Prescriptions during Pregnancy in Lombardy: Temporal Tr… (10.3390/pharma2030021)		0.00	0
36	Use of Hand Sanitizers in COVID-19 Prevention: A Comprehensi… (10.3390/pharma2030022)		0.00	14
37	Detectable Vancomycin Stool Concentrations in Hospitalized P… (10.3390/pharma2040024)		0.00	7
38	Impact of Antibiotic De-Escalation on Antibiotic Consumption… (10.3390/pharma2040025)		0.00	8
39	Blood Pressure Control in the DIAbetes and LifEstyle Cohort… (10.3390/pharma2040026)		0.00	0
40	Analyzing Black Market Sales of the Second-Line ADHD Medicat… (10.3390/pharma2040027)		0.00	0
41	A Retrospective Review of COVID-19 Medicines Information Que… (10.3390/pharma2040028)		0.00	0
42	Literature Review of Safety Event Reporting in Observational… (10.3390/pharma2040029)		0.00	0
43	Helpful, Unnecessary, or Harmful: A Systematic Review of the… (10.3390/pharma2040030)		0.00	3
44	Direct Oral Anticoagulants’ Consumption and Expenditure in t… (10.3390/pharma3010001)		0.00	4
45	Rescue Therapy for Supratherapeutic Concentrations of Calcin… (10.3390/pharma3010002)		0.00	2
46	Characteristics and Outcomes of Patients on Tofacitinib for… (10.3390/pharma3010003)		0.00	0
47	“My Addiction Doesn’t Define Me”—Experiences of Stigma among… (10.3390/pharma3010004)		0.00	7
48	Remdesivir and the Liver: A Concise Narrative Review of Remd… (10.3390/pharma3010005)		0.00	6
49	Crises in Antimicrobial Stewardship: Misuse of Clarithromyci… (10.3390/pharma3010006)		0.00	14
50	Opioid Prescribing for Noncancer Patients—Issues of Drug The… (10.3390/pharma3010007)		0.00	1